Literature DB >> 24493638

MicroRNAs and human diseases: diagnostic and therapeutic potential.

Raihana Maqbool1, Mahboob Ul Hussain.   

Abstract

MicroRNAs (miRNAs) are endogenous, non-coding small RNAs that regulate gene expression at the post-transcriptional level. Recent studies have shown that miRNAs are aberrantly expressed in various human diseases, ranging from cancer to cardiovascular hypertrophy. The expression profiles of the miRNAs clearly differentiate the normal from the pathological state and thus their potential as novel biomarkers in the diagnosis and prognosis of several human diseases is immense. Emerging data on the role of miRNAs in the pathogenesis of various human diseases have paved the way to test their ability to act as novel therapeutic tools. In the present review, we will explore the current knowledge about the role of miRNAs in various human diseases. In addition, we will focus on the emerging evidences demonstrating the potential of miRNAs as novel biomarkers and the strategies to use them as therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24493638     DOI: 10.1007/s00441-013-1787-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  19 in total

1.  microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.

Authors:  Aparna Lakshmanan; Anna Wojcicka; Marta Kotlarek; Xiaoli Zhang; Krystian Jazdzewski; Sissy M Jhiang
Journal:  Endocr Relat Cancer       Date:  2014-11-17       Impact factor: 5.678

Review 2.  Electrochemical biosensors for measurement of colorectal cancer biomarkers.

Authors:  Wenxian Zhang; Guangchun Xiao; Jun Chen; Li Wang; Qiongzheng Hu; Jian Wu; Wenhong Zhang; Ming Song; Jinwei Qiao; Chonghai Xu
Journal:  Anal Bioanal Chem       Date:  2021-03-05       Impact factor: 4.142

Review 3.  Micro (mi) RNA and Diabetic Retinopathy.

Authors:  Praveen Sharma; Shailendra Dwivedi; Sunita Tiwari; Pankaj Kumar Singh; Amit Pal; Sandeep Kumar
Journal:  Indian J Clin Biochem       Date:  2022-01-14

4.  The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.

Authors:  Raihana Maqbool; Rabiya Rashid; Rehana Ismail; Saif Niaz; Nisar Ahmad Chowdri; Mahboob Ul Hussain
Journal:  Cell Oncol (Dordr)       Date:  2015-09-03       Impact factor: 6.730

5.  The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.

Authors:  Shuangyan Lin; Mingyuan Zhao; Yanbo Lv; Genxiang Mao; Shiping Ding; Fang Peng
Journal:  Aging (Albany NY)       Date:  2021-04-26       Impact factor: 5.682

6.  Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.

Authors:  Wei-Yang Tao; Xiao-Shuan Liang; Yang Liu; Chun-Yang Wang; Da Pang
Journal:  Int J Biol Sci       Date:  2015-01-01       Impact factor: 6.580

7.  Ribonucleic acid (RNA) biosynthesis in human cancer.

Authors:  Omar S Hajjawi
Journal:  Cancer Cell Int       Date:  2015-02-21       Impact factor: 5.722

8.  Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.

Authors:  Xiaoyan He; Zhimei Zhang; Ming Li; Shuo Li; Lihua Ren; Hong Zhu; Bin Xiao; Ruihua Shi
Journal:  BMC Cancer       Date:  2015-08-06       Impact factor: 4.430

9.  miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.

Authors:  Omer Faruk Karatas; Esra Guzel; Ilknur Suer; Isin D Ekici; Turhan Caskurlu; Chad J Creighton; Michael Ittmann; Mustafa Ozen
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 10.  Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection.

Authors:  Hicham Mansour
Journal:  Front Genet       Date:  2014-08-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.